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ABSTRACT
Telomeres,theprotein–DNAcomplexesattheendsof
eukaryotic chromosomes, are essential for chromo-
some stability, and their maintenance is achieved
by the specialized reverse transcriptase activity
of telomerase or the homologous recombination
pathway in most eukaryotes. Here, we identified a
human helicase, hPif1 that inhibits telomerase
activity. The primary sequence and biochemical
analysis suggest that hPif1 is a potential homologue
of Escherichia coli RecD, an ATP-dependent 50 to
30 DNA helicase. Ectopic expression of wild-type,
but not the ATPase/helicase-deficient hPif1, causes
telomere shortening in HT1080 cells. hPif1 reduces
telomerase processivity and unwinds DNA/RNA
duplex in vitro. hPif1 preferentially binds telomeric
DNA in vitro and in vivo. We propose that the mech-
anism of hPif1’s inhibition on telomerase involves
unwinding of the DNA/RNA duplex formed by
telomerase RNA and telomeric DNA, and RecD
homologues ineukaryotes mayhaveevolvedgaining
additional functions.
INTRODUCTION
Telomeres are the nucleoprotein structures that are positioned
at eukaryotic chromosomal ends. The primary role of
telomeres is to insulate the chromosomal ends from both
fusion with other ends and from nucleolytic digestion (1,2).
The telomeric DNA, which typically consists of tandem
repeats of guanine-rich sequences, is essential for telomere
function. In humans, each chromosome end bears 5–15 kb
of TTAGGG/CCCTAA repeated DNA, which is maintained
by telomerase (3) and/or alternative lengthening of telomere
(ALT) pathway (2,4).
Telomerase, as found in most organisms, is a specialized
reverse transcriptase that uses a small segment of an integral
RNA subunit as template to extend the 30 end of the G-rich
strand of telomeres (3,5). In humans, telomerase activity
attributed to hTERT (the catalytic protein subunit) and hTR
(the RNA subunit) is readily detected in germline cells, high-
proliferative cells and many types of cancer cells (6). How-
ever, telomerase activity is minimal in most somatic cell
lineages (7). Consistent with this, telomeres in most types
of human somatic cells shorten with increasing age or with
repeated passaging in culture (8,9). The introduction of
hTERT into some normal primary human cells has been
shown to halt telomere shortening and prevent the cells
from entering into senescence (10,11). Although telomerase
activation does not induce transformation (12), immortaliza-
tion of primary human cells and the extensive proliferation of
most adult human cancer cells require telomerase activity
(13,14). Inhibition of telomerase activity in tumor cells caused
telomere shortening and resulted in cell crisis (14–16). For
these reasons, repression of telomerase activity might act as an
adjuvant therapy for the treatment of human cancer (17).
In most human tumor cells, telomere length is stably main-
tained by balancing the result of telomere attrition and
telomere elongation by telomerase (18,19). The telomere
elongation activity of telomerase is determined by both the
level of telomerase expression and the accessibility of
telomerase to telomere ends (20). Telomere binding protein
complex is a major player in the latter factor (20,21). It has
been suggested that the human duplex telomeric DNA-binding
protein TRF1 and TRF2 recruit TIN2 and hRAP1 to telomeres
andnucleate theformationofaspecializedchromatinstructure
to prevent the access of telomerase (22,23). In addition, long
telomeres in human cells can form a T-loop structure where
the 30 single-stranded telomere overhang is inserted into the
double-stranded telomere region. This renders DNA terminus
*To whom correspondence should be addressed. Tel: 86 21 54921078; Fax: 86 21 54921076; Email: jqzhou@sibs.ac.cn
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
  The Author 2006. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access
version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press
areattributedastheoriginalplaceofpublicationwiththecorrectcitationdetailsgiven;ifanarticleissubsequentlyreproducedordisseminatednotinitsentiretybut
only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
Nucleic Acids Research, 2006, Vol. 34, No. 5 1393–1404
doi:10.1093/nar/gkl029inaccessible totelomerase (24). The formation ofT-loop struc-
ture appears to be facilitated by TRF1 and TRF2 (24–26).
Furthermore, telomeric single-stranded DNA-binding protein
hPot1 may also act as a repressor of telomerase (27) since the
30 end cannot simultaneously binds the hPot1 protein and the
telomerase RNA component.
Recently, we determined that the Saccharomyces Pif1
helicase and its paralogue Rrm3 helicase are involved in
telomere DNA replication (28,29). Rrm3p appears to promote
the progression of the replication fork through telomeres
(29,30). Pif1p, unlike Rrm3p, inhibits telomere lengthening
through the telomerase pathway (28). A proposed mechanism
for yeast Pif1p’s inhibition of telomerase activity is to
release Est2p/Tlc1 complex from telomeric DNA (31).
PIF1-like genes are found in diverse organisms, for example
in Schizosaccharomyces pombe, Candida maltosa,
Caenorhabditis elegans, Drosophila melanogaster and
Homo sapiens (28,32). The Pif1p homologue in S.pombe,
called Pfh1p (Pif1 homologue 1), is essential for cell viability
(33). Because the fundamental mechanism of telomere rep-
lication is highly conserved from yeast to mammals, the
elucidation of the function of telomerase and its regulators
in yeast has provided insights that are relevant to the function
of their homologues in humans. The yeast Pif1p is the proto-
type of this helicase subfamily, and the potential humanhomo-
logue wasreferredashPif1(28).Althoughthepartialsequence
comparison of the yeast Pif1p, Rrm3p, Pfh1p and its potential
human homologue (hPif1) indicate  32, 32 and 36% primary
sequence identity over 438, 395 and 377 amino acid resi-
dues, respectively (28), the existence of human Pif1 helicase
was unresolved. To address these issues, we have cloned the
cDNA encoding human Pif1, overexpressed and puriﬁed the
recombinant protein, and characterized its enzymatic activity
in vitro. Our in vivo and in vitro data suggested that hPif1
regulates telomere elongation by decreasing telomerase pro-
cessivity, possibly via a mechanism that involves the unwind-
ing of hTR from telomeric DNA by hPif1.
MATERIALS AND METHODS
Oligonucleotides for assays
Oligonucleotides were synthesized and puriﬁed by Takara.
The tel18 is (TTAGGG)3. The ran18 is GTTGTAAAACGA-
CGGCCA. The ssDNA is GTTGTAAAACGACGGCCAGT-
GAAT. The ssRNA is GUAAUCAUGGUCAUAGCUGU-
UUCCUGUGUGAAAUU. The 50 end 25mer and 30 end
35mer oligonucleotides were 50-GTTGTAAAACGACGGC-
CAGTGAATT-30 and GTAATCATGGTCATAGCTGTTTC-
CTGTGTGAAATT (for DNA helicase assay), or 50-GUU-
GUAAAACGACGGCCAGUGAAUU-30 and GUAAUCAU-
GGUCAUAGCUGUUUCCUGUGUGAAAUU (for RNA
helicase assay).
Human Pif1 constructs, cell lines and antibodies
The full-length human Pif1 coding sequence was PCR amp-
liﬁed from HEK 293 cell cDNA library using the forward
primer 50-TTTGAATTCCATATGCTCTCGGGCATAGAG-
GCGGCGGCAGGGGAA-30 and reverse primer 50-GCTCT-
AGAATTCCATATGTCAGAGGTTTGGGTCCATGTTCT-
CCTGGTCTGAGGC-30. The 1.9 kb PCR products were
digested with EcoRI and NdeI, and inserted into pUC19.
Sequencing results from two independent clones indicated
that both clones contained a single open reading frame
(ORF) with several nucleotide differences, which may have
been due to PCR errors. These sequences were further ana-
lyzed by comparison with the human genome and EST
databases. The correct fragments of the two sequenced
clones were sub-cloned to obtain the hPIF1 gene with the
full-length ORF. The hPif1
K234A point substitution mutation
was generated by site-directed mutagenesis kit (Clontech).
The hPif1, hPif1
K234A, Myc-tagged hPif1 (hPif1
myc)o r
green ﬂuorescent protein (GFP)-tagged hPif1 constructs
were transiently or stably transfected into HT1080 cell
lines. For hPif1 antibody production, Glutathione S-
transferase (GST)-fusion fragment of hPif1 N-terminal (76–
230 amino acid) or C-terminal (438–550 amino acid) was
prepared from Escherichia coli and injected into rabbits to
generate antisera. The anti-hPif1 antibodies were puriﬁed
with antigen afﬁnity column.
Expression and purification of recombinant
human Pif1 protein
GSThPif1DN (167–641 amino acid) or its Walker A mutant
GSThPif1
K234ADN was sub-cloned into ScaI and SmaI sites
of pEG(KT) and overexpressed in a protease-deﬁcient
Saccharomyces cerevisiae strain (BCY123). Recombinant
proteins were puriﬁed according to the protocols described
previously (30).
DNA-dependent ATPase assay
The standard reaction mixture (10 ml) contained 20 mM
Tris–HCl (pH 7.5), 100 mg/ml BSA, 0.5 mM DTT, 10 mM
MgCl2, 333 pM [g-
32P]ATP (3000 Ci/mmol) (Amersham
Biosciences), 1 mM cold ATP, 100 ng/ml oligonucleotide
and 10 nM of the protein to be tested. Reactions were incub-
ated for 30 min at 37 C and were terminated by addition of
10 ml of 50 mM EDTA. An aliquot of 1 ml of reaction mixture
was spotted on a polyethyleneimine cellulose plate
(J.T. Baker),which wasdevelopedin0.8MLiCl. Theamounts
of [
32P]orthophosphate released were visualized using a
PhosphorImager (Molecular Dynamics).
DNA/RNA or DNA/DNA helicase assay
Each oligonucleotide was end-labeled with [g-
32P]ATP by T4
polynucleotide kinase (New England BioLab). A total of
2.5 pmol of both the
32P-end-labeled 25mer and 36mer oli-
gonucleotides were annealed in a 75 ml reaction mixture with
2.5 pmol of single-stranded M13mp7 DNA, whose hairpin
region was digested with EcoRI. The annealed substrates
were puriﬁed with the Chroma Spin-1000 column (BD Bios-
cience). The 20 ml reactions contained 1 nM DNA substrate
and 50 nM recombinant protein in reaction buffer [20 mM
HEPES (pH 7.4), 5 mM MgAc2, 5 mM ATP, 100 mg/ml BSA,
5% glycerol, 1 mM DTT], and were incubated at 37 C for
30 min. Reactions were stopped by addition of 5 ml 100 mM
EDTA. Products were analyzed by electrophoresis on a 10%
polyacrylamide/TBE gel [89 mM Tris borate (pH 8.3), 2 mM
EDTA]. After electrophoresis, the gel was dried and quantiﬁed
by PhosphorImager.
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The reaction mixture contained 100 nM
32P-labeled oligonuc-
leotide,25mM HEPES–NaOH (pH7.5), 100mM NaCl, 1mM
EDTA, 5% glycerol and 50 nM recombinant protein. Different
oligonucleotides were added to appropriate concentration as
nonspeciﬁc competitor where needed. Reactions were incub-
ated for 30 min at 30 C and loaded on to a 6% PAGE gel for
electrophoresis at 4 C. After electrophoresis, the gel was dried
and quantiﬁed by PhosphorImager.
Inducible gene expression system
HT1080 Tet-Off cell line was purchased from BD Clontech.
hPIF1
myc or hPIF1
myc (K234A) was cloned into the tTA-
regulated expression vector pTRE2Hyg (BD Clontech).
Cells were stably transfected with either pTRE2-hPIF1 or
pTRE2-hPIF1
K234A which confers hygromycin resistance.
For each construct, about 30 G418-resistant clones were
expanded. To induce the overexpression of hPif1 or
hPif1
K234A in the stable transfectants, cells were grown in
the absence of doxycycline in DMEM medium supplemented
with either 50 mg/ml hygromycin (rpi) or 100 mg/ml G418
(rpi). To repress the overexpression of hPif1 or hPif1
K234A, the
cells were growninthe presence ofdoxycycline(500ng/ml)in
DMEM medium. The hPif1 protein was detected by
immunoprecipitation–Western blotting using anti-Myc anti-
body or anti-hPif1 antibody.
Telomeric repeat amplification protocol assay
Approximately 10
6 HT1080 cells were lysed in 1 ml of
CHAPS buffer [10 mM Tris–HCl (pH7.5), 1 mM EDTA,
0.5% CHAPS, 10% glycerol] and  10
2 cells were used in
each assay. The telomerase activity was assessed using the
TRAP-eze telomerase detection kit (Chemicon) according to
the manufacturer’s instruction. To examine the effects of
indicated proteins on telomerase activity in vitro, various
amounts of proteins were added into the reaction and incub-
ated for 30 min at 30 C before subjecting to PCR ampliﬁca-
tion. Products were separated on 12.5% native gel, which was
then stained with SYBR Green.
In vitro reconstitution of human telomerase
hTERT was expressed from phTERT and hTR subunit from
phTR+1 using the TnT quick-coupled transcription /transla-
tion system (Promega). Each 100 ml reaction contained 80 ml
of TnT-quick mix, 5 ml of PCR enhancer, 2 mlo f1m M
methionine and 2 mg of supercoiled phTERT and BamHI,
HindIII-cut phTR+1 plasmid DNA. After incubation at
30 C for 2 h, the product was mixed with 10 ml of 100%
glycerol and stored at  80 C.
Direct telomerase activity assay
The 20 ml reaction contained 8 ml of reconstituted telomerase
complex, 50 mM Tris-OAc (pH 8.3), 50mM KCl, 1 mM
MgCl2, 5 mM DTT, 1 mM5 0-biotinylated (TTAGGG)3
(Takara), 1 mM[ a-
32P]dGTP (3000 Ci/mmol), 2.5 mM cold
dGTP, 1 mM dATP, 1 mM dTTP. The reaction mix was incu-
bated at 30 C for 30 min. The elongation step was terminated
by incubating with 50 ml of stopping buffer (10 mM EDTA,
0.1 mg/ml RNase A, 0.5 mg/ml Proteinase K, 0.1% SDS) for
30 min. Then 50 ml of pre-washed Streptavidin-coated Dyna-
beads M-280 Streptavidin suspension (Dynal Biotech) in buf-
fer A [10 mM Tris–HCl (pH 7.5), 1 M NaCl, 0.5 mM EDTA]
was added. A total of 1 fmol of radiolabeled and biotinylated
TGTGTGTGGG was also included as a loading control. The
elongation product was immobilized onto the magnetic beads
at room tempreture for 30 min and followed two times wash
with buffer A and three times wash with buffer B [10 mM
Tris–HCl (pH 7.5), 0.5 mM EDTA]. The beads were resus-
pended in 95% deionized formamide and boiled for 20 min.
Telomerase reaction products were analyzed by 15%
polyacrylamide-urea gel electrophoresis. After electrophor-
esis, the gel was dried and quantiﬁed by PhosphorImager.
For processivity analysis, the radioactive signal for
each band detected by PhosphorImager was quantiﬁed with
ImageQuant software (Molecular Dynamics). The pro-
cessivity was determined according to the formula:
Pi ¼
Pn
j¼iTj
Ti (i ¼ 1, 2, 3, 4,...,n), where Pi means that the
sum of radioactive signal for each band above position +i
(including position +i) is divided by the radioactive signal
of position +i, where Ti represents the radioactive signal for
the primer +i position; the Pi value reﬂects the relative ability
of the enzyme to pass through the position +i.
Genomic blotting and telomere length estimation
Genomic DNA was isolated from cells as described (19) at the
indicated population doubling (PD), digested to the comple-
tion with HinfI/RsaI and quantiﬁed by ﬂuorometry using
Hoechst 33258 dye. DNA was size-fractionated on a 0.7%
agarose gel, transferred to HyBond N+ membranes (Amer-
sham), crosslinked by ultraviolet (UV), and probed with
32P-labeled repeated telomeric probe. The membrane was
exposed to a phosphor screen (Molecular Dynamics). The
median length of telomeric restriction fragments was determ-
ined as described in Li et al. (34) using ImageQuant software
after scanning with a PhosphorImager.
Immunoprecipitation
Cells were scraped, washed with cold phosphate-buffered
saline (PBS), and lysed in RIPA lysis buffer [50 mM Tris–
HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1.0% Na-
deoxycholate, 1.0% NP-40, 0.1% SDS]. Cell extract from
10
7 cells was incubated with either 5 mg of pre-immune
sera or polyclonal anti-hPif1-N (76–230 amino acid) antibod-
ies overnight at 4 C. The antibody–protein complexes were
precipitated by Protein A agarose beads (Amersham
Biosciences), washed four times with NETN buffer [20 mM
Tris–HCl (pH 8.0), 100 mM NaCl, 1 mM EDTA, 0.5%
NP-40], and eluted with SDS–PAGE loading buffer. The
eluted proteins were separated by SDS–PAGE, transferred
to nitrocellulose membranes (Amersham Biosciences), and
probed with polyclonal anti-hPif1-C (438–550 amino acid)
antibodies.
Chromatin immunoprecipitation (ChIP) assay
ChIP assays were performed as described (27). Brieﬂy, 10
6
cells were trypsinized and lysed. The DNA and associated
proteins in the extracts were crosslinked, fragmented
by sonication, and then immunoprecipitated with either
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clonal anti-hPif1 antibodies. The DNA was then puriﬁed,
denatured at 65 C and dot blotted on to a Hybond N
+ mem-
brane (Amersham Bioscience). The membrane was washed
with 0.5 M Tris–HCl (pH 8.0) containing 150 mM NaCl,
air dried, blocked and hybridized with
32P-labeled telomere
probe or Alu probe (50-GCAGTGAGCCGAGATCGCGC-
CACTGCACTCC-30), and exposed on phosphor screen
(Molecular Dynamics). The quantiﬁcation was done with
the ImageQuant software. All lysates were normalized for
cell number. For the total telomeric DNA samples, three
12.5 ml aliquots (corresponding to one-eighth of the amount
of lysate used in the immunoprecipitations) were processed
along with the rest of the samples at the step of reversing the
crosslinks. The average of the telomeric signal in three total-
fractions were taken for the reference value (total DNA), and
the percentage of each immunoprecipitation sample was cal-
culated based on the signal relative to the corresponding total
DNA signal.
RESULTS
Molecular cloning of cDNA encoding human Pif1
We previously reported that the putative human Pif1 and yeast
Pif1p share 32% identity over a 438 amino acid region (28), as
a hPIF1 cDNA clone with the full-length gene was not avail-
able then. A Drosophila cDNA clone (accession no.
NM_134938) which encodes a homologue of yPif1p was
later found by a homology search in GeneBank. When the
Drosophila clone was used to search the NCBI database, we
found two human clones (accession nos: AK026345 and
BC033254), which have homology with the N and C terminus
ofyPif1p, respectively.Inaddition, thesetwo human cloneslie
in the chromosome 15q22.31,  9 kb apart, suggesting that
they may comprise parts of the hPIF1. Subsequently, a 1.9 kb
hPif1 gene was obtained by PCR from a HEK 293 cell cDNA
library, and cloned into expression vectors (see Materials and
Methods). The deduced amino acid sequences indicated that
the hPIF1 is a 641 amino acid protein with a predicted molecu-
lar weight of  71 kDa, and contains seven conserved motifs
characteristic of DNA helicases (Figure 1A and Supplement-
ary Figure 1) (35).
hPif1 is a potential homologue of E.coli RecD
Helicases utilize the energy of NTP hydrolysis to catalyze the
unwinding of double-stranded nucleic acids, and play import-
ant roles in many cellular processes (35). Most helicases from
various organisms have been classiﬁed into superfamily I and
II (SFI and SFII), and contain seven conserved helicase motifs
(I,Ia, II,III,IV, VandVI)(36). These motifsare usually found
clustered ina relatively short region over 300–500 amino acids
long. The conserved helicase motifs of I to VI in SFI share
little similarity with the corresponding motifs of that in SFII.
The high degree of conservation of Pif1 subfamily helicases in
S.cerevisiae, S.pombe, C.maltosa, C.elegans, D.melanogaster,
Mus musculus and H.sapiens (28,32) suggests that they might
have evolved from a common ancestor which plays funda-
mental and conserved roles in nucleic acid metabolism.
To seek cousins of Pif1, we searched multiple gene and
protein databases. Because the conserved helicase motifs
are short and degenerate, it is difﬁcult to identify homologues
even in the same superfamily when the full-length sequences
of helicase are analyzed with traditional BLAST or FASTA
computer programs.Instead,we searched the Clusterof Ortho-
logous Groups of proteins (COG) database, and discovered
that hPif1, as well as other members of Pif1 subfamily, clus-
tered with RecD of E.coli. As a result of the large phylogenetic
distance, the sequence identity betweenthem was low (<20%).
Figure 1. Alignment of amino acid sequences of Pif1 and the E.coli RecD protein. (A) Alignment of conserved motifs in hPif1, yPif1 and E.coli RecD proteins.
Roman numerals indicate helicase motifs and the letters indicate unknown motifs. (B) Sequence conservation of conserved motifs in hPif1, yPif1 and E.coli RecD
proteins.H.C.SFI:helicaseconsensusofsuperfamilyI.+,hydrophobic;o,hydrophilic;3,Ser/Thr;4,Lys/Arg;5,Phe/Tyr/Trp;6,Leu/Ile/Val/Met;x,anyaminoacid.
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of an arbitrarily-chosen statistical cut-off, but rather uses the
best-hit rule, which accommodates both slow- and fast-
evolving proteins (37). Therefore, we could readily search
for putative ancestral proteins of most eukaryotic helicases,
and classify the members of superfamilies into different COGs
(Supplementary Table 1). Because hPif1 identiﬁed RecD in
our COG search, we then compared the protein sequences of
hPif1 and RecD. The helicase motifs of hPif1 have high
sequence identity with the consensus helicase motifs in
RecD proteins (Figure 1 and Supplementary Figure 1). In
contrast to other members of SFI, Pif1 subfamily and proka-
ryotic RecD subfamily do share some other conserved motifs,
designated as motifs A, B, C (Figure 1 and Supplementary
Figure 1), whose functions are unknown, in addition to the
helicase motifs. All these data imply that eukaryotic Pif1 sub-
family belongs to RecD subfamily.
hPif1 is an ATPase and a 50 to 30DNA helicase
In general, homologues share similar biochemical properties.
As previously reported, E.coli RecD is a subunit of RecBCD
complex, and possesses ATP-dependent 50 to 30DNA helicase
activity (38,39). To characterize hPif1 activity in vitro,w e
tried to overexpress and purify full-length recombinant
hPif1 protein. However, the full-length hPif1 was difﬁcult
to overexpress and/or purify even when expressed in hetero-
logous expression systems, including those utilizing bacteria,
yeast and insect cells. According to the full-length sequence
alignment of Pif1 subfamily and RecD (data not shown), the
N-terminals of these proteins are not conserved, suggesting
that they may not be essential for the conserved enzymatic
activity. Thus, we overexpressed the recombinant N-terminal
deletedhPif1that containsthe seven conserved helicasemotifs
with an N-terminal GST fusion (
GSThPif1DN) in S.cerevisiae
and puriﬁed it to near homogeneity. A mutant
GSThPif1
K234ADN, in which the conserved Lysine in the
ATP binding domain (helicase motif I in Figure 1B) was
changed to an Alanine, was overexpressed and puriﬁed in
parallel (Figure 2A).
Subsequently, we measured ATPase activity of the recom-
binant proteins, and found out that the recombinant
GSThPif1DN could efﬁciently hydrolyze ATP in the presence
of both Mg
2+ and single-stranded DNA (Figure 2B, lanes 3–5).
Little ATPase activity of
GSThPif1DN was detected in the
presence of RNA or double-stranded DNA (Figure 2B,
Figure 2. Enzymatical characterization of recombinant hPif1 protein. (A) Expression and purification of recombinant
GSThPif1DNo r
GSThPif1
K234ADN protein in
S.cerevisiae. Purified protein were resolved by 10% SDS–PAGE and detected by Coomassie blue staining (left panel) or immunoblotting (right panel). (B) ATP
hydrolyzing activity of
GSThPif1DNo r
GSThPif1
K234ADN protein. A total of 333 pM radiolabeled ATP and 1 mM cold ATP were incubated with 10 nM indicated
protein and other reagents as shown. The products were developed in a polyethylimine (PEI) cellulose plate and visualized on a Molecular Dynamics Phosphor-
Imager. (C) DNA helicase polarity assay of
GSThPif1DNo r
GSThPif1
K234ADN proteins. The DNA substrate was linearized M13mp7 single-stranded DNA to which
radiolabeled36merand25merDNAoligonucleotideshadbeenannealed.Thesubstratewasincubatedwith50nMindicatedproteininreactionbufferandexamined
by 12% native gel. Asterisk represents the radiolabeled site at 50 end of primers.
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stranded DNA. No ATPase activity was detected with the
GSThPif1
K234ADN (Figure 2B, lane 8). Thus, hPif1 confers
Mg
2+-dependent and single-stranded DNA-stimulated ATP
hydrolysis activity.
To analyze hPif1’s helicase activity, a standard helicase
polarity assay (30) was performed, using a linearized
single-stranded M13mp7 DNA annealed with a 35mer and
25mer oligonucleotide at the 50 and 30 ends, respectively.
DNA helicases will move along the single-stranded DNA
and displace at least one of the oligonucleotides. As shown
in Figure 2C, recombinant
GSThPif1DN, as well as yPif1p,
displaced the 35mer oligonucleotide, while the ATPase-
deﬁcient
GSThPif1
K234ADN did not. We conclude that the
hPif1 is an ATP-dependent 50 to 30DNA helicase. Collectively,
these data indicate that recombinant hPif1 has enzymatic prop-
erties in vitro that resemble those of both yPif1p and RecD
protein.
Overexpression of ATPase/helicase-functional hPIF1
results in telomere shortening
The messenger RNA of hPif1 has been reported to be present
in some human tissues (40,41), however, these reported clones
matched only with either N or C terminus sequence of our
clone. To analyze the expression of hPif1 mRNA and protein,
we examined 12 transformed cell lines derived from different
human tissues. The hPif1 transcripts were detected in most of
tested cell lines (Figure 3A); however, the protein was
undetectable when the total cell lysates were subjected to
Western blotting (data not shown). We then enriched the
hPif1 by immunoprecipitation, following Western blotting
and ﬁnally detected a faint band only in the extract of
Wrl68 hepatocytes (Figure 3B), which corresponded to the
size of hPif1 detected in transiently transfected HT1080
cells. This result suggests that the expression of hPif1 protein
in tested cells is very limited. To examine whether hPif1 could
be ectopically overexpressed in human cell lines, we transfec-
ted hPif1 construct into HT1080 ﬁbrosarcoma cells, in which
endogenous expression of hPif1 protein was minimum, to
establish stable cell lines. The ectopic expression of hPif1
or hPif1
myc was detected as a single band in the extract of
the stable cell lines by Western blotting after immunoprecip-
itation (Figure 3C), suggesting that hPif1 has only one form,
unlike yPif1 which exists as both nuclear and mitochondrial
forms with different molecular sizes (42). Overexpressed
GFP-fused hPif1 was observed in nucleus (data not shown),
suggesting that no mitochondrial form of hPif1 exists.
To investigate the role of hPIF1 in telomere DNA replica-
tion, we took advantage of Tet-Off HT1080 cell line (19,20), a
telomerase-positivehumanﬁbrosarcoma-celllinewith astable
telomere length, for inducible expression of full-length hPif1
containing a C-terminal Myc epitope (hPIF1
myc) or its
ATPase-deﬁcient mutant hPIF1
myc(K234A) (Figure 2B).
Western analysis with anti-hPif1 antibodies showed that doxy-
cycline controlled the expression of wide-type or mutant hPif1
proteins in clonal Tet-Off HT1080 cell lines transfected with
the constructs (Figure 4A and B). At PD one after removal of
doxycycline, the expression of hPif1 was induced and
remained relatively stable thereafter. The expression of
hPif1 was repressed with the re-introduction of doxycycline
back into the culture medium. Expression of wild-type or
mutant hPIF1 proteins did not affect the overall growth rate
of the cells for at least 150 PDs (data not shown).
We then studied the effects of long-term overexpression of
hPIF1
myc or hPIF1
myc (K234A) on telomere length in these
transfected cells. Cells overexpressing hPif1 showed gradual
telomeric shortening after induction. The change of telomere
length was not discernible at one PD when the expression of
hPif1 was already fully induced, but a shortening of terminal
restriction fragments was obvious between 15 and 35 PDs
(Figure 4C and E). The loss of telomeric sequences was
also evident from a reduction in the TTAGGG hybridization
signal (Figure 4C and E). Telomere shortening was detected in
all ﬁve tested cell lines that overexpressed hPIF1
myc (Table 1).
In these cells (T2, T9, T10, T12 and T15), the decline of
telomere length was dependent on the absence of doxycycline.
After extensive passaging the cell lines (55 PDs), the
telomeres shortened by 0.5–1.5 kb, and the rate of telomere
shorteningvariedinthedifferentcelllines from10to27bpper
PD (Table 1). A control Tet-Off HT1080 cell line transfected
with mutated hPIF1 had stable telomeres over 130 PDs and
there was no effect on telomere length after inducing hPIF1
myc
(K234A) overexpression (Figure 4D and F). These results
indicate that hPIF1 negatively regulates telomere length and
that such inhibition requires the ATPase/helicase activity
of hPif1.
Repression of hPif1 overexpression recovers
telomere length
It has been suggested that the establishment of stable telomere
length could be determined by dynamic factors such as
telomerase activity, the rate of telomere shortening and the
levels of other factors that control telomere length (20). The
overexpression of hPif1 for more than 35 PDs seemed to
Figure 3. Expression of hPIF1 in transformed human cell lines. (A) Northern
blot analysisofhPIF1expressionin12 celllines,andtheRNAfrom293Tcells
transientlytransfectedwithhPIF1plasmidaspositivecontrol.Theprobewasa
fragment of hPif1 gene (1335-1926 nt). Actin was detected as internal control.
(B) Western blot analysis of the endogenous hPif1 immunoprecipitated from
Wrl68 and MRC5 cells, and total extract of transient expression of hPif1 in
293T cells was used as positive control. The primary antibody for Western
analysis was against hPif1 C-terminal (438–550 amino acid), while the anti-
body for immunoprecipitation was against hPif1 N-terminal (76–230 amino
acid). (C) Western analysis of overexpression of hPif1, hPif1
K234A or hPif1
myc
in HT1080 stable cell lines as in (B).
1398 Nucleic Acids Research, 2006, Vol. 34, No. 5promote a new equilibrium in telomere length (Figure 4C and
E). At this stage, telomere length became stable and no further
changes were observed when the culture was grown for an
additional 50 PDs (data not shown). If the changes in telomere
length were caused by hPif1 overexpression, suppression of
hPif1wouldreleasethe inhibition.Therefore,doxycyclinewas
added inthe culturemedium torepressthe expressionofhPif1,
and the telomeres in the HT1080 Tet-Off cells were analyzed.
In the T15 clone (Figure 4C and E), shortened telomeres
showed gradual elongation over 40 PDs at a rate of 38 bp
per PD. The short telomeres in other clones (T2, T9, T10 and
T12) also showed similar increase in length, and were even-
tually stabilized (Table 1), indicating that silencing of ectopic
Figure 4. hPif1inhibitstelomere elongationin vivo.( Aand B) Tetracycline-regulatedexpressionof hPif1
myc (A) and hPif1
myc (K234A)(B)proteins in a hPif1
myc-
containingTet-OffHT1080cellline(T15)andahelicase-deficienthPif1
myc(K234A)-containingTet-Offcellline(Tm14),respectively.Immunoblottinganalysisof
the hPif1
myc and hPif1
myc (K234A) overexpression in cells was performed under induced, uninduced and repressed conditions. Whole-cell extract at the indicated
PDs was immunoprecipitated using anti-hPif1-N (76–230 amino acid) antibody. Immunoprecipitates were detected with anti-hPif1-C (438–550 amino acid)
antibody.Allcellsweregrowninparallelwithorwithoutdoxycycline;repressedcellswerewithdoxycyclineafterpassagingcellsfor55PDsatinducedconditions.
Total extract of transient expression of hPif1 in 293T cells was used as a positive control. HCIg (heavy chain of immunoglobulin) served as loading controls. (C)A
hPif1
myc-containingTet-OffHT1080cellline(T15)wasgrownforindicatedPDinmediawithunderuninducedorrepressed(withdoxycycline)orinduced(without
doxycycline) conditions, and genomic DNA was isolated at the indicated PD. The DNA was digested with HinfI/RsaI, was separated on an agarose gel, Blots were
probed with a TTAGGG repeat probe to detect telomeric restriction fragments. Molecular weight standards are indicated to the left of the gels. (D) A helicase-
deficient hPif1
myc (K234A)-containing Tet-Off cell line (Tm14) was grown for 120–130 PD under uninduced or repressed or induced conditions. Genomic DNA
samples from the cells at the indicated PD were subjected to TRF analysis as described above. (E and F) Representative genomic Southern blots of (C) and (D).
The plot represents mean telomere length values. Open circles: uninduced conditions; filled circles: induced conditions; open square: repressed conditions (at and
after PD55).
Table 1. Telomere length affected by hPif1
Tet-Off
HT1080
clones
hPif1
construct
DTelomere length at
PD 55
Shorten
ratio (bp/PD)
Elongate
ratio (bp/PD)
+Dox (kb)  Dox (kb)
Tm11 hPif1
myc(K234A) +0.1 +0.3 0 +4
Tm14 hPif1
myc(K234A) +0.2 +0.3 0 +5
T2 hPif1
myc 0  0.5  10 +13
T9 hPif1
myc +0.1  0.7  13 +18
T10 hPif1
myc  0.1  0.8  15 +20
T12 hPif1
myc +0.1  1.1  20 +28
T15 hPif1
myc +0.2  1.5  27 +38
aPD: population doubling; Dox: doxycycline.
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starting population. These data argue that down-regulation
of hPif1 expression promotes telomere elongation, and the
telomere shortening caused by up-regulation of hPif1 expres-
sion is likely a direct effect.
hPif1 inhibits telomerase activity in vitro
Since overexpression of hPif1 causes telomere shortening, it is
possible that the hPif1 inhibits telomerase activity. Therefore,
we analyzed the effect of hPif1 on telomerase activity in vitro
by using a PCR-based telomeric repeat ampliﬁcation protocol
(TRAP) assay. Telomerase-containing extracts were prepared
from HT1080 cell lysate. In the ﬁrst step of the reaction,
telomerase adds a number of telomeric repeats (GGTTAG)
on to the 30 end of a substrate oligonucleotide. In the second
step, the extended products are ampliﬁed by PCR, generating a
ladder of products with six base increments on a native gel.
With the increase of recombinant
GSThPif1DN, telomerase
ladders were decreased (Figure 5A, lanes 4–9). Interestingly,
yPif1p showed a similar effect (Figure 5A, lane 10), suggest-
ing that yPif1p and hPif1 are functional counterparts involved
in the regulation of in telomere length (28,31,32). In contrast,
GSThPif1
K234ADN lacked any detectable inhibitory activity
(Figure 5A, lane 3). These data indicated that hPif1 inhibits
telomerase activity in vitro.
hPif1 reduces processivity of human telomerase in vitro
Although the results of the TRAP assay (Figure 5A) suggested
that hPif1 inhibits telomerase activity, it could not discern
which aspect, i.e. the primer binding or processivity of
telomerase is affected by hPif1. Processivity is deﬁned as
the ability of telomerase to undergo multiple reaction cycles
without being released from telomeric DNA. To determine
whether hPif1 affects primer binding or processivity of
human telomerase, we performed direct telomerase activity
assay, which allows us to assess telomerase processivity, i.e.
the actual number of telomeric repeats added to the primer
(telomerase ladder). When the recombinant
GSThPif1DN was
Figure 5. hPif1 inhibits telomerase activity in vitro.( A) TRAP assay of telomerase. Each reaction contains extract from  100 HT1080 cells. Protein was added as
indicated. The equivalent cell lysate treated with RNase A acted as a negative control. Arrows point to the 36 bp internal control (S-IC) for PCR amplification.
(B) Direct telomerase activity assay performed with 1 mM (TTAGGG)3 in presence or absence of
GSThPif1DNo r
GSThPif1
K234ADN. Lane 1 (control): in vitro
reconstitutedtelomerase.Lanes2and3:thereactionalsocontained10nMindicatedproteinand5mMATP.(C)QuantificationofthetotalDNAsynthesisrelativeto
synthesis in absence of hPif1. (D) Processivity analysis of telomerase in each reaction. (E) Unwinding of DNA/RNA hybrid by hPif1. The DNA substrate was
linearized M13mp7 single-strandedDNA to which radiolabeled 36merand 25merRNA oligonucleotideshad been annealed. The reactionwith50 nM recombinant
protein is indicated on top of each lane. The products were examined by 12% native gel.
1400 Nucleic Acids Research, 2006, Vol. 34, No. 5added into the telomerase reaction, the total DNA synthesis of
telomerase was reduced (Figure 5B and C), arguing that hPif1
inhibits telomerase activity, which is consistent to the TRAP
assay result. Strikingly, the presence of recombinant
GSThPif1DN resulted in a signiﬁcant decrease of the repeated
ladders formed by multiple telomeric repeats addition
(Figure 5B, lanes 1, 2 and Figure 5D), indicating that hPif1
dramatically reduces the processivity of human telomerase. In
contrast, little difference could be seen when recombinant
GSThPif1
K234ADN was added into the telomerase reaction
(Figure 5B, lanes 1, 3 and Figure 5C and D), suggesting
that ATPase/helicase activity is essential for the inhibitory
effect of hPif1 on telomerase processivity.
hPif1 has the ability to dissociate RNA from DNA
We then investigated mechanism of the inhibition of
telomerase by hPif1. Our initial suspicion was that hPif1
could dissociate telomerase RNA from its telomeric DNA.
However, even though the helicase activity of Pif1 seems
important for its function, but the activity for unwinding
DNA/DNA with a 50 to 30polarity (Figure 2C) could not
explain its inhibitory effect on telomere elongation because
telomeres have 30 single-stranded sequence. Therefore, we
tested the activity of hPif1 using radiolabeled 25mer and
35mer RNA oligonucleotides annealed with M13mp7 single-
stranded DNA. In the presence of either yPif1 or GSThPif1DN,
the 35mer RNA oligonucleotide was released from the
M13mp7 DNA (Figure 5C, lanes 2 and 4) (30), while
helicase-deﬁcient hPif1 or yPif1 did not show the unwinding
activity (Figure 5C, lanes 3 and 5). Hence, we were able to
conclude that hPif1 possesses ATP-dependent activity that
unwinds a DNA/RNA duplex with 50 to 30polarity in vitro.
To investigate the possibility of a physical interaction
between hPif1 and hTERT, we performed co-
immunoprecipitation and the yeast two-hybrid assay. Both
assays produced negative results, suggesting that hPif1 is
unlikely to interact with hTERT (data not shown). Taken
together, our ﬁndings suggest that hPif1 inhibits telomerase
activity by unwinding the duplex of telomerase RNA-
telomeric DNA hybrid.
hPif1 binds human telomeric DNA in vitro and in vivo
If the inhibition of hPif1 on telomerase is direct, it may
interact with telomeric DNA. To test this, we carried out
gel-shift assay of single-stranded human telomeric DNA or
random DNA using puriﬁed recombinant
GSThPif1DNo r
GSThPif1
K234ADN. Random single-stranded DNA was added
as molecular competitor. The recombinant
GSThPif1DN could
Figure 6. hPif1bindstelomericDNAinvitroandinvivo.(A)Gel-shiftassayofradiolabeledhumantelomericDNA(tel18)orrandomsingle-strandedDNA(ran18)
in presence or absence of 50 nM
GSThPif1DNo r
GSThPif1
K234ADN. 10-, 100- and 1000-fold excess of unlabeled cold oligonucleotide was added as indicated. ATP
or ADP was added after the reactions were incubated at 30 C for 30 min, and followed another 15 min incubation. The products were analyzed on 6% native gels.
(B) Telomeric ChIP on HT1080 Tet-Off cell clones inducibly expressing hPif1
myc using the indicated antibodies or pre-immune serum. Dot blots were hybridized
with a TTAGGG repeat probe. HT1080 Tet-Off cell clone T15 was induced to express hPif1 for 7 days and were processed alongside uninduced cells, and hPif1
expressionwasrepressedafterinduction.Positivecontrolispolyclonalanti-TRF1antibodies(ab1428,Abcam).(C) DuplicatedotblotswasprobedforAlurepeats.
(D) Quantification of the signals in (B). Averaged duplicate signals obtained with total DNA samples were used as 100% value for the quantification.
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telomeric sequence, but exhibited higher afﬁnity for telomeric
DNA because 100-fold more random DNA appeared not to be
able to compete with telomeric DNA (Figure 6A, lanes 2 and
3).In addition, ATP enhanced, while ADPreduced the binding
of hPif1 to telomeric DNA (Figure 6A, lanes 6 and 7).
Interestingly, ATPase-deﬁcient mutant hPif1 also bound to
single-stranded DNA, although with a slightly lower afﬁnity
(Figure 6A, lane 8), implying that ATP acted as a positive
modulator rather than being an absolute requirement for the
binding process. These results indicate that hPif1 is a single-
stranded DNA-binding protein and has a preference for
TTAGGG telomeric repeat in vitro.
To address whether hPif1 interacted with telomeric DNA
in vivo, we performed ChIP experiments with extracts pre-
pared from the cells either before induction of hPif1, after
induction of hPif1, or upon repression of induced hPif1.
The presence of telomeric DNA was detected using a dot
blot assay with a probe incorporating TTAGGG repeats
(Figure 6B). The telomere-associated protein TRF1 was
used as a positive control. We found that the afﬁnity-
puriﬁed anti-hPif1 antibodies pulled down hPif1 with associ-
ated telomeric DNA only when the expression of hPif1 was
induced (Figure 6B). When a non-telomeric probe such as Alu
DNA was used in the ChIP analysis, only the input extracts
generated a positive signal (Figure 6C). These results sugges-
ted that hPif1 interacts with telomeric DNA in vivo, and that
the inhibitory effect of hPif1 on telomere elongation might be
direct.
DISCUSSION
In this work, we identiﬁed a human helicase hPif1. Like the
yeast Pif1, hPif1 is able to unwind DNA/DNA (Figure 2C) and
DNA/RNA duplex(Figure 5E), and isa putative homologue of
E.coli RecD (Figure 1 and Supplementary Figure 1). Ectopic
expression of wild-type, but not ATPase/helicase-deﬁcient
hPif1 causes telomere shortening in telomerase-positive
cells, and repression of ectopically expressed hPif1 restored
the equilibrium of telomere length (Figure 4). The hPif1 pro-
tein preferentially binds telomeric TTAGGG repeats
(Figure 6A), and decreases telomerase processivity in vitro
(Figure 5B–D). The inhibitory effect of hPif1 on telomere
elongation is likely to be direct because hPif1 associates
with telomeric DNA in vivo (Figure 6B). We propose that
hPif1’s ability to unwind the DNA/RNA duplex formed by
telomerase RNA and telomeric DNA deﬁnes the mechanism
whereby hPif1 inhibits telomerase activity (Figure 7).
Helicases are the motor proteins that utilize the energy of
NTP hydrolysis to transiently catalyze the unwinding of
duplex nucleic acids, and are found to be essential in many
cellular processes involving DNA and RNA. Pif1 helicase
subfamily belongs to the helicase superfamily I (SFI). How-
ever, when the members of Pif1 helicase subfamily were ana-
lyzed using the COG database, they were grouped in RecD
COG, while WRN and BLM helicases fell into RecQ COG
(Supplementary Table 1). We propose that hPif1and the
other members of Pif1 subfamily are RecD-like helicases.
The sequence alignment of conserved helicase motifs sup-
ports this hypothesis. In addition to the helicase motifs,
Figure 7. Model for hPif1 as a telomerase inhibitor. hPif1 dissociates telomerase RNA from telomeric DNA.
1402 Nucleic Acids Research, 2006, Vol. 34, No. 5Pif1 subfamily and prokaryotic RecD subfamily share some
conserved motifs, named A, B and C (Figure 1 and Supple-
mentary Figure 1), which are not found in other members of
SFI. Besides the sequence similarity, functional studies also
strengthened this idea. RecD helicase in E.coli has been repor-
ted to form a complex with RecBC to repair DNA breaks by
homologous recombination via a concerted action of helicase
and nuclease activities (39). The yeast Pif1p has previously
been shown to participate in mitochondrial DNA recombina-
tion (42). The Saccharomyces Rrm3p, which is a paralogue of
Pif1p, is required to reduce the converged forks during rDNA
replication (29). Thus, like RecD, the yPif1p and Rrm3p are
involved in DNA recombination, and it remains a possibility
that hPif1 also takes part in other cellular processes. Also of
note, hPif1 does not appear to be the only RecD-like helicase
in humans. The mammalian DNA helicase B, which is
required for the onset of chromosomal DNA replication,
shares homology with RecD (43) (Supplementary Table 1).
Thus, it will be interesting to further study the functions of
RecD-like helicase in mammals.
The members of Pif1 helicase subfamily studied so far all
appear to contribute to telomere maintenance. In S.pombe,
mutation of the Pfh1p results in modest telomere shortening
(44). In S.cerevisiae, the Rrm3 helicase promotes the passage
of the replication fork through telomere and sub-telomere
regions (30). Pif1p inhibits telomere elongation by reducing
the processivity of the telomerase and by removing the
telomerase from telomere ends (31), In humans, overexpres-
sion of hPif1 causes telomere shortening (Figure 2B), and this
negative regulation is most likely achieved through the inhibi-
tion of telomerase (Figure 5A–D). Repression of overex-
pressed hPif1 resulted in telomere elongation (Figure 2B).
Therefore, the general inhibitory functions of hPif1 and
yPif1p in telomeres are similar (31). However, the precise
mechanisms of telomerase inhibition by hPif1 and yPif1p
may not be identical: hPif1 appears to reduce the telomeric
repeat addition processivity (Figure 5B–E), while yPif1p
releases telomerase from telomeric DNA in an active form
after completion of one round of DNA synthesis (31). In all
cases, the effects of these proteins on telomeres require
ATPase/helicase activity. These observations from studies
in vitro and in vivo lead us to propose a model depicted in
Figure 7. hPif1 binds a single-stranded G-rich region that is
proximal to the double-stranded region of the telomere, while
telomerase binds the region distal to single-stranded region
and the telomerase RNA pairs with the tip of 30 overhang
(Figure 7). In this model, Pif1 would slide along the DNA
in a 50 to 30direction to access and disentangle the telomerase
RNA-telomeric DNA hybrid, thereby inhibiting telomere
elongation. ATP and ADP might act as regulators of the pro-
cess. When hPif1 binds ATP, it may undergo a conformational
change that facilitates it’s binding to ssDNA and provide the
energy to move along the telomeric DNA. With the binding of
ADP by hPif1, access to ssDNA may be restricted, or altern-
atively, it may be released from the telomeric DNA (Figure 7).
However, the question of whether hPif1 is capable of directly
removing hTERT from telomeric DNA in vivo needs further
investigation.
The inhibition of telomere elongation as a result of DNA/
RNA unwinding orchestrated by hPif1 represents a different
regulatory mechanism for human telomerase from those
previously proposed (19,20,27,44–46). The notion has
emerged that helicases are required for telomere replication.
Recent studies indicate that the Saccharomyces Sgs1 helicase
(47–49)andhumanWRNhelicase(50),twomembersofRecQ
subfamily, are involved in telomere maintenance. However,
unlike Pif1 helicase, which seems to fall in RecD subfamily
and regulates telomere length through inhibition of
telomerase, the Sgs1 helicase participates in a telomerase-
independent pathway for telomere lengthening (48,49). The
WRN helicase, in which a mutation causes the Werner syn-
drome, is required for dissociating alternate or secondary
structures at telomere, to allow for replication, repair and
telomerase activity at the telomere end (50,51). However,
whether loss of function of hPif1 would correlate with any
of human disease needs further investigation.
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